GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Forward PE Ratio

Hamilton Thorne (TSX:HTL) Forward PE Ratio : 52.63 (As of Jun. 07, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Forward PE Ratio?

Hamilton Thorne's Forward PE Ratio for today is 52.63.

Hamilton Thorne's PE Ratio without NRI for today is 0.00.

Hamilton Thorne's PE Ratio for today is 0.00.


Hamilton Thorne Forward PE Ratio Historical Data

The historical data trend for Hamilton Thorne's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Forward PE Ratio Chart

Hamilton Thorne Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-12 2024-05
Forward PE Ratio
26.18 23.36 50.25 45.87 39.22 33.00 51.28

Hamilton Thorne Quarterly Data
2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 44.05 26.18 26.95 40.65 19.80 23.36 29.59 98.04 40.98 50.25 66.67 57.14 37.45 45.87 35.21 37.74 31.95 39.22 39.37 54.64 41.15 33.00 23.98

Competitive Comparison of Hamilton Thorne's Forward PE Ratio

For the Medical Devices subindustry, Hamilton Thorne's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamilton Thorne's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's Forward PE Ratio falls into.



Hamilton Thorne Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Hamilton Thorne  (TSX:HTL) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Hamilton Thorne Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines